PGNY Earnings & Financial Statements
Progyny, Inc.
$27.84
+$0.45(+1.64%)
60
Overall
65
Value
66
Tech
50
Quality
Market Cap
$2.14B
Volume
773.95K
52W Range
$16.10 - $33.07
Target Price
$34.00
PGNY earnings and financial statements: Progyny, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PGNY Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.29B | $1.17B | $1.09B | $786.91M | $500.62M |
| Cost of revenue | $984.18M | $913.86M | $849.80M | $619.59M | $388.49M |
| Operating income | $85.28M | $67.45M | $62.18M | $23.34M | $32.34M |
| EBITDA | $100.38M | $86.38M | $72.97M | $25.23M | $33.64M |
| Net income | $58.52M | $54.34M | $62.04M | $30.36M | $65.77M |
| EPS (diluted) | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $742.43M | $607.10M | $756.62M | $542.99M | $358.06M |
| Total liabilities | $226.39M | $185.04M | $203.19M | $166.02M | $106.24M |
| Shareholders’ equity | $516.04M | $422.06M | $553.43M | $376.97M | $251.82M |
| Cash and equivalents | $112.24M | $162.31M | $97.30M | $120.08M | $91.41M |
| Long-term debt | $24.00M | $16.41M | $17.24M | $6.48M | $7.42M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $210.19M | $179.10M | $188.81M | $80.39M | $26.04M |
| Capital expenditure | -$18.41M | -$5.41M | -$3.64M | -$3.24M | -$2.13M |
| Free cash flow | $191.78M | $173.70M | $185.17M | $77.15M | $23.91M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PGNY | $27.84 | +1.6% | 773.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |